AVIFFA RTI, liofilizat za pripremu suspenzije, za purane
AVIFFA RTI, liofilizat za pripremu suspenzije, za purane
Authorised
- Turkey rhinotracheitis virus, strain VCO3, Live
Product identification
Medicine name:
AVIFFA RTI, liofilizat za pripremu suspenzije, za purane
Active substance:
- Turkey rhinotracheitis virus, strain VCO3, Live
Target species:
-
Turkey
Route of administration:
-
Ocular use
-
In drinking water use
Product details
Active substance and strength:
-
Turkey rhinotracheitis virus, strain VCO3, Live2.30/log10 tissue culture infective dose 501.00Actuation
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension/use in drinking water
Withdrawal period by route of administration:
-
Ocular use
-
Turkey
-
Meat and offal0day
-
-
-
In drinking water use
-
Turkey
-
Meat and offal0day
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Croatia
Available in:
-
Croatia
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
- UP/I-322-05/17-01/263
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it
in another language below.
Croatian (PDF)
Published on: 25/07/2024
How useful was this page?:
